How can clinicians, specialty societies and others evaluate and improve the quality of apps for patient use?
How can clinicians, specialty societies and others evaluate and improve the quality of apps for patient use?
复制标题
DOI：
10.1186/s12916-018-1211-7
复制
发表时间：
2018-12-03
期刊：
影响因子：
9.3
通讯作者：
Wyatt, Jeremy C.
中科院分区：
文献类型：
--
作者：
Wyatt, Jeremy C.
与健康相关的应用程序在全球范围内具有增强健康和预防疾病的巨大潜力，但它们的质量目前差异太大，临床医生无法有信心向患者推荐它们。主要的质量问题是可疑的应用程序内容，与他们捕获的患者数据的广泛共享相关的隐私损失，不准确的建议或风险估计以及缺乏影响研究。这也许可以解释为什么目前关于健康相关疾病患者使用应用程序的证据不足且不一致。Main text针对患者使用的健康相关应用程序存在许多担忧，例如监管不力和对技术的隐性信任。然而，包括用户、开发人员、健康专业人员和应用程序分销商在内的各种利益相关者可以采取一些行动来解决这些问题，从而提高应用程序的质量。这篇文章的重点是使用检查表，可以应用到应用程序，新的评估方法和建议，临床专业组织如何开发一个低成本的策划应用程序存储库，明确的风险和质量criterions.ConclusionsClinicians和专业学会必须采取行动，现在，以确保他们使用高质量的应用程序，支持患者在可用的应用程序之间进行选择，并提高开发中的应用程序的质量。资助者还必须投资于研究，以回答有关应用程序的重要问题，例如临床医生和患者如何决定使用哪些应用程序以及哪些应用程序因素与有效性相关。
BackgroundHealth-related apps have great potential to enhance health and prevent disease globally, but their quality currently varies too much for clinicians to feel confident about recommending them to patients. The major quality concerns are dubious app content, loss of privacy associated with widespread sharing of the patient data they capture, inaccurate advice or risk estimates and the paucity of impact studies. This may explain why current evidence about app use by people with health-related conditions is scanty and inconsistent.Main textThere are many concerns about health-related apps designed for use by patients, such as poor regulation and implicit trust in technology. However, there are several actions that various stakeholders, including users, developers, health professionals and app distributors, can take to tackle these concerns and thus improve app quality. This article focuses on the use of checklists that can be applied to apps, novel evaluation methods and suggestions for how clinical specialty organisations can develop a low-cost curated app repository with explicit risk and quality criteria.ConclusionsClinicians and professional societies must act now to ensure they are using good quality apps, support patients in choosing between available apps and improve the quality of apps under development. Funders must also invest in research to answer important questions about apps, such as how clinicians and patients decide which apps to use and which app factors are associated with effectiveness.